Stem Cell

Stem Cell

Created using Figma

最後の更新

2018/09/16

幹細胞ICO
 私たちは専門家、研究所、診療所、病院、そして非営利団体とのネットワークを拡大しています。私たちの究極の目標は、治療を必要とする人々をそれぞれのニーズに合った適切なプロのソリューションとエキスパートと結びつけることです。 SCIでは、他の多くのサービスが現代社会にあるので、そのような接続は便利であり、あなたの指先で行われるべきだと私は思います。何が起源であれ、私たちは誰から来たのかに関係なく、幹細胞・イノベーション・アプリケーション(SCIアプリケーション)を通して幹細胞スペシャリストに即座に接続できます。
Main-Sale
2018/11/21
2019/01/17
100% 完成した
$2 520 000
100% ゴール 完成した
past
  • 1 SCIA
    =
    0.15 USD
Pre-Sale
2018/09/17
2018/10/09
100% 完成した
$2 520 000
100% ゴール 完成した
past
トークンの詳細
ティッカー
SCIA
許容通貨
ETH, LIT, BITC
会社の詳細
登録国
Gibraltar
追加の詳細
プラットフォーム
Ethereum
KYC
はい
カテゴリー
プラットフォーム

約 Stem Cell

> Stem Cell Innovations(SCI)は、意欲的な研究者、専門の医療専門家、献身的な投資家、そして21世紀の2つの最も革新的なイノベーションを結集するユニークなプラットフォームを構築する革新的なエンジニアのネットワークです。とブロックチェーンて民族学。

> 2013年初めにCamden RAD、LLCという名称で設立されて以来、SCIは世界中の幹細胞の研究開発において重要な役割を果たしてきました。 。幹細胞科学の分野におけるSCIの活動は、世界中の新しい幹細胞の発見だけでなく、この分野の進歩に直接貢献しています。

>幹細胞は、人間の体に見られるユニークなタイプのマルチセルです。それは、疾患や病状の治療、身体部分の回復および回復に使用するための新しい細胞の開発において、そして我々の研究開発とともに、今後さらに多くの応用において無数の応用を提供することができる細胞の未分化集合である。

>今日まで、SCIの研究分野は整形外科的、神経学的、および肺の状態、ならびに腫瘍学的幹細胞適用を含んでいた。 SCIによって行われた研究は医学のこれらの分野で進歩を遂げたが、

特徴

現在、米国および世界中の病院や組織がこの分野を推進するために幹細胞研究を行っています。今日までのところ、大多数のケーススタディは肯定的な発見を明らかにしています。米国以外の地域での臨床研究では、幹細胞が治療の一形態として成功裏に使用されてきました。幹細胞治療と技術は医学の研究と発見の最先端にあり続けており、幹細胞は医学界のいっそう重要な部分になると予測しています。

研究をさらに進めるだけでなく、SCIは幹細胞利用エコシステムを通じて幹細胞バンクを提供することを計画しています。両親は1つの安全なアプリケーションを通して、回収キットの注文、宅配便の受け取りの予約、幹細胞の保管の申し込みができます。 SCIは幹細胞の保管と治療の選択肢の世界的ネットワークをユーザーに提供するので、親にとって幹細胞銀行業務のプロセスを合理化し、収集と保管のためのコストを削減するというユニークな立場にあります。

SCIは、ユーザーが医療ニーズに合わせて独自のカスタムメイドの合成幹細胞治療薬を購入できるようにする独自の処方を開発しました。患者の同意と生年月日、血液型、アレルギー、診断、そしていくつかの健康関連の質問といった最小限の情報で、SCIは我々が開発した独自のアルゴリズムに差し込まれる内部の安全な実験室シーケンスを実行するでしょう。このアルゴリズムにより、特定の治療を必要とする個人のためにカスタムデザインの合成幹細胞を構築することができます。 SCIはこの画期的な技術を誇りに思っており、世界と共有することにさらに興奮しています。幹細胞研究の進歩とSCIからのアクセシビリティは世界を生命のための優れた革新へと導くでしょう。

 

技術情報

Protecting confidential user information is vital to the success of a system like the one we are proposing. to ensure security and privacy, Stem Cell Innovations will require users signing into the SCIApplication to provide information and generate a unique identifier within the SCI ecosystem. A unique identifier is an alphanumeric string of information that is assigned to a specific piece of data in an electronic database; in this case, the SCI platform and application. users will be given a unique identifier that will be generated using a proprietary algorithm, which will be used and stored using blockchain technology. the SCI unique identifier will act as users’ keys within the SCI network. through cryptographic methods, the data used to generate the key will be kept secret and secure, able to be parsed only by the SCI decoder. unique identifiers enable access to customized stem cell services and therapies offered throughout the expansive SCI network to our users. SCI will provide personalized stem cell solutions to patients using our platform, and as the SCI network and suite of services grow, users who opt into these services will be apprised of advancements and new treatment options as they become available.

SCI plans to run on dual blockchain platforms. the first platform will be built on an ethereum base for token use only, and it will be powered by the eRC20 platform. the second blockchain will be a custom application designed and built by SCI engineers tailored to fit the healthcare environment.
SCI has decided to build its own blockchain for storing and processing patient stem cell records. this customized blockchain is known as SCIChain. SCIChain will use the Hyperledger fabric network, which will be designed to use smart contracts to protect data and ensure only authorized individuals have access to user data. SCI engineers realize that the Hyperledger fabric blockchain has unique functionalities that differ from other blockchain types that fit with the needs of SCI’s vision and product.

Smart contracts are the gatekeepers of the SCIApplication. users will be free to change their settings at will should their treatments change or preferences change. using mathematical equations equal to the eRC20 platform, SCI ensures user privacy. the straightforward validation associated with a blockchain environment is a secure process that ensures data integrity. furthermore, a cryptography public key will be added to the SCIChain and application to promote a higher standard of security. the symmetric-encrypted key used by SCIChain is 2048-bit, which is a supremely secure method of data transformation in today’s technology-based world.

%name%ロードマップ

  • white_paper_v1.1.pdf

  • Please check our whitepaper

Stem Cell チーム

検証済み 86%

注意。確認されていないメンバーは実際にチームのメンバーではないというリスクがあります

Moe Galal
Chief Executive Officer / Founder
検証済み
Ben Barel
Chief Operations Officer / Co-Founder
検証済み
Ali Alrashidi
Chief Technology Officer / Co-Founder
検証済み
Matt Galal
Chief of Staff / Co-Founder
検証済み
Kobi Barel
Operations Engineer / Co-Founder
検証済み
John Glavinovich
Medical Director
検証済み
Philip Glukhovsky,
Health Informatics Manager
検証済み
Roger Williams
VP of Marketing
検証済み
Liz Curlett
VP, PR & Corporate Communications
検証済み
Candice Kouchache
Business Development
検証済み
Ahmed Elsantawi
VP of International Human Resources
検証済み
David Marmon
Web Designer
検証済み
Rakel Apodaca
Product Manager
未確認
Michelle Chavon
Marketing
未確認

顧問

検証済み 33%

注意。確認されていないメンバーは実際にチームのメンバーではないというリスクがあります

10 ICOs

$5 540 000

Boyan Josic
Advisor
未確認

5 ICO

$7 040 000

Marc X. Ellul
Advisor
未確認
Roger Shortz
Advisor
検証済み
Pantea Nakieen
Advisor
未確認
Shahab Sajadi
Advisor
検証済み

2 ICO

$5 040 000

Igor Soshkin
Advisor
未確認

Stem Cell インタビュー

Moe Galal
As a team member, сan you tell us about your role in the ICO project?
Provided clarifications, corrections, and data query resolution with study sites Stem Cell Labs; assisted with quality assurance audits. Developed and reviewed clinical reports, progress/status reports, and final study reports. Build Block-chain to construct the healthcare System, the future of healthcare (Stem Cell) with the future of technology (Block-chain). Form Stem Cell Labs Worldwide.

As the previous founder of Global Medical Management, Inc, founded in 2001, I'm able to tap into my vast network in the medical management community to get the word out about SCI and lends my business expertise to the company in a variety of ways. In order to become the premier provider of stem cell services around the world, myself and the team at SCI continue to collaborate, inspire, and innovate at a time when the medical industry needs not only a face lift, but a complete makeover.
What do you think about idea?
With the better part of 2018 behind us, we look toward what the future holds for SCI and the stem cell community at large. Q4 will see the sale and distribution of the ERC-20 tokens through the Ethereum platform which will drive the continued research and development of stem cell therapies, access, engagement, and treatment around the world. With breakthroughs happening in the stem cell industry on a regular basis, it’s important to pay attention to how this complex, yet soon-to-be-highly-accessible treatment options are changing the world. Much work has yet to be done, but here are just some of the exciting things happening in the stem cell industry at large.

Restoring Heart Function
Regeneration is Made Possible
Creating New Life
Making People Healthy Again

SCI Will Bridge the Gap for Research and Application, idea that never been executed. SCI is working to create research opportunities like these and many others and will connect these innovated treatments to the people who could benefit from them the most with the blockchain-based platform that will provide secure and transparent transactions and interactions to procedures, specialists who can provide such treatments, education, insight, and more. Research and development like what we’ve seen in the first half of 2018 encourages our mission and fuels our vision to bring these life-changing therapies and discoveries to people around the world.
Ben Barel
As a team member, сan you tell us about your role in the ICO project?
healthcare professional with over 20 years of experience managing and overseeing corporate operations, human resources, and compliance reporting in a variety of settings As the Coo, a key member of SCI’s leadership team.
I have taken on a vital leadership role in the building, implementing, and overseeing all of SCI’s corporate operations, processes, workflows and procedures. He plays a critical role in helping to shape and guide the future growth and development of the organization.
What do you think about idea?
This is an amazing project that will

1. bring global awareness for stem cell

2. connect everyone (professional, providers, scientists, and users) around the stem cell.

3. Secure user information on blockchain

4. decentralize stem cell records
Ali Alrashidi
As a team member, сan you tell us about your role in the ICO project?
Chief Technology Officer / Co-Founder
I have a background rich in programming and development, I manages SCI’s blockchain platform. My support in furthering academic research in the field of blockchain will allow SCI to grow.
What do you think about idea?
SCI's platform is "Next Generation" Technology, it's paving the way for advancements in Stem Cell & Healthcare on Blockchain. I'm thrilled to be apart of this journey.
Matt Galal
As a team member, сan you tell us about your role in the ICO project?
Stem Cell Innovations is changing the face of health care by expanding access to stem cell research.
What do you think about idea?
SCI, we are devoted to the international research development & implementation of stem cell therapy.
Kobi Barel
As a team member, сan you tell us about your role in the ICO project?
Responsibilities such as problem solving which includes finding the problem , testing the problem solving and concluding the problem is a daily task as an engineer of operations for companies as innovate radiology Imaging and Stem cell Innovations.
What do you think about idea?
We are bringing two complicated but great tools together to form the best next thing out there for everyone else to follow. I take pride that I am involved in a project that will be used 100 years from now!!
John Glavinovich
As a team member, сan you tell us about your role in the ICO project?
John Glavinovich, M.D. -Medical Director
With over 30 years’ experience in hospital-related clinical, management and operational practices, Dr. Glavinovich a non-traditional approach to the work being done by the team
What do you think about idea?
For the past 20 years I've had an extensive interest in alternative and cutting age medicine. I've worked in recent years on a preventative, proactive and restorative approach to medical treatment including Stem Cell Therapy, The Idea of bringing Stem Cell services to a secure network is important for me and patients alike. I'm excited to see this company reach it's potential and change the way people receive Stem Cell Treatment.
Philip Glukhovsky,
As a team member, сan you tell us about your role in the ICO project?
To consult in proper utilization of stem cell technology and new stem cell research. To maintain a streamlined, patient oriented app interface.
What do you think about idea?
Wonderfully innovative and novel approach that will be the beginnings of the future of modern healthcare.
Roger Williams
As a team member, сan you tell us about your role in the ICO project?
My role at SCI is as their VP of Marketing, I'm known for my innovative approach to marketing and my experience will greatly benefit SCI as the company expands it network and services in the stem cell industry.
What do you think about idea?
Over the years I've worked with many startup companies, whether I believed in the cause or not, but when I heard SCI's platform model, I immediately jumped on board, knowing it was going to change the future for regenerative medicine.
Liz Curlett
As a team member, сan you tell us about your role in the ICO project?
Liz is responsible for strategic development and tactical implementation of media production programs for Stem Cell Innovations. Activities include presentation, video and visual content program oversight, and in-person appearances and speaking engagements when needed. Liz works closely with all members of the SCI team, to create effective and engaging content in order to update stakeholders and build the SCI Brand.
What do you think about idea?
I believe SCI is building an elegant, multi-faceted solution to need that is without boarders. While some countries are still deciding how they want to regulate and/or facilitate stem cell therapy, the market projections and growing demand cannot be ignored. In addition, SCI has selected blockchain technology to address additional marketplace inefficiencies and to ensure this solution remains accessible.

I am thrilled to be part of a team and look forward to contributing my time, resources and experience to the SCI mission.
Candice Kouchache
As a team member, сan you tell us about your role in the ICO project?
I work closely with the SCI team/board to ensure the success of the project, helping to develop internal practices and overall support.
What do you think about idea?
The idea of SCI is innovative and fresh, they have combined two of the worlds smartest inventions, creating an application that will change the way people look at “stem cells” & “Blockchain”
Ahmed Elsantawi
As a team member, сan you tell us about your role in the ICO project?
VP of International Human Resources
15 years’ experience in Human Resources allows the company to ensure the organization grows in a sustainable and efficient way.
What do you think about idea?
Stem Cells on Blockchain
Stem Cell Innovations is changing the face of health care by expanding access to stem cell research, development, and treatments around the world using blockchain technology.
David Marmon
As a team member, сan you tell us about your role in the ICO project?
I am the designer of all the different web / presentation components as well as the developer of the website.
What do you think about idea?
Very, very solid idea. Much needed and revolutionary. Being a part of this team continues to be great.
Roger Shortz
As a team member, сan you tell us about your role in the ICO project?
As an advisor with SCI I bring to the table knowledge as a board certified neurosurgeon with decades of experience. I have advanced training and interest in minimally invasive spinal surgery, as well as complicated spinal instrumentation and fusion.
What do you think about idea?
Stem Cell Innovation is bringing two major issues together to solve the problems we as medical professional have currently. Treatment for with Stem Cells is so "taboo" it is difficult to receive, on the other hand privacy for our patients is threaten daily with the lack of Security with HIPPA. Blockchain technology can change all that. Glad to be of assistance in the process.
Shahab Sajadi
As a team member, сan you tell us about your role in the ICO project?
Adviser in the Pharmaciducal aspect , including a detail data comparison of compounding to stem cell treament.
What do you think about idea?
SCI is bring the future of medicine to the public and i am amazed with what we as a company are doing for the upcoming future.

Stem Cell 最後のニュース

  • 情報の更新には時差がある可能性があるため、各ICOプロジェクトに関する正確な情報は、公式Webサイトまたはその他の通信チャネルを通じて検証する必要があります。
  • この情報は、ICO資金への投資に関する提案やアドバイスではありません。関連情報を自分で徹底的に調査し、ICOの参加を決定してください。
  • このコンテンツに関して修正すべき問題や問題があると思われる場合、またはご自身のICOプロジェクトをリストに載せたい場合は、電子メールでご連絡ください。
免責事項とリスクに関する警告をお読みください。 免責事項とリスクの警告を表示します。
    

免責事項&リスクの警告     

このオファーは、オファーと他の一般に公開されている情報によってのみ提供される情報に基づいています。トークンの販売または交換のイベントは、ICOholderとは全く無関係であり、ICOholderはそれに関与していません(技術サポートやプロモーションを含む)。 ICOholderとの関係がない人物からのトークンの売り上げは、顧客が全体のトークンセクター内で行われている活動を追跡するのを助けるためにのみ表示されます。この情報は、あなたが頼りにするべきアドバイスにはなりません。弊社サイトのコンテンツに基づいて、行動を取る、または控える前に、プロフェッショナルまたはスペシャリストの助言を得るか、またはお客様のデューデリジェンスを実施する必要があります。トークンの取得に関してコントリビュータによって入力された条件は、トークンの発行者とトークンの発行者であり、ICOholderはそのようなトークンの販売者ではありません。 ICOholderは、トークンの販売に関して第三者が行ったいかなる表明についても法的責任を負いません。また、契約違反の申し立ては、ここに記載されたトークン発行会社に対して直接行われなければなりません。     

このトークン販売の性質、妥当性または合法性について懸念がある場合は、 info@icoholder.com までご連絡ください。あなたの懸念事項に関する詳細情報と一緒に。